{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:47:30Z","timestamp":1791877650594,"version":"4.3.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["BE2018659"],"award-info":[{"award-number":["BE2018659"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Plan of Suzhou City","award":["SKY2021038"],"award-info":[{"award-number":["SKY2021038"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"Objective<\/jats:title>The role of biomarkers in the early diagnosis and prognosis prediction of tumors has been paid more and more attention by researchers. Mucins are markers that have been found to have an abnormal expression in many tumors in recent years, which have been proved to have a predictive effect on the prognosis of tumors such as cholangiocarcinoma and colon cancer. However, whether it can predict the prognosis of pancreatic cancer remains unknown. The purpose of our study is to investigate whether the mucins and their subtypes are related to the prognosis of patients with pancreatic cancer.<\/jats:p><\/jats:sec>Methods<\/jats:title>We systematically searched the Pubmed, Embase, and Cochrane Library for all eligible studies on the relationship between mucin and the prognosis of patients with pancreatic cancer up to November 2021. We used R 4.12 to calculate the combined risk ratio (HR) and 95% confidence interval (CI). For studies that did not provide HR values, we used scientific methods to calculate their values as accurately as possible. We used fixed effect model due to low heterogeneity. Subgroup analysis and sensitivity analysis were used to study heterogeneity. The funnel plot and Egger test were used to test whether the publication bias existed. The trim and filling method were used to evaluate the impact of publication bias on the results of the study.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 18 studies were included in this meta-analysis, including 4 subtypes of mucin family members and 1643 patients. There was a slight heterogeneity between studies (I2 = 24.4%, P = 0.14). Meta-analysis showed that MUC4 (HR = 2.04, 95%CI 1.21;3.45), MUC16 (HR = 2.10, 95%CI 1.31;3.37), and whole mucin (HR = 1.32, 95%CI 1.07;1.63). The expression level was negatively correlated with the prognosis of pancreatic cancer patients, MUC1 (HR = 1.09, 95%CI 0.77;1.54), MUC5 (HR = 1.03, 95%CI 0.47;2.25) The expression level was not related to the prognosis of pancreatic cancer patients.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>The meta-analysis demonstrated that the overall expression level of mucin and the expression levels of MUC4 and MUC16 were important prognostic predictors for pancreatic cancer patients. MUC1 and MUC5 had no predictive value for the prognosis of pancreatic cancer patients. Future studies should validate these and other promising biomarkers.<\/jats:p><\/jats:sec>Trial registration<\/jats:title>PROSPERO registration number is CRD42021291962.https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021291962<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0269612","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T17:33:16Z","timestamp":1655400796000},"page":"e0269612","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-9746","authenticated-orcid":true,"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"7","key":"pone.0269612.ref001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"AP Klein","year":"2021","journal-title":"Nature reviews Gastroenterology & hepatology"},{"key":"pone.0269612.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis","volume":"520","author":"J Cai","year":"2021","journal-title":"Cancer Lett"},{"issue":"9","key":"pone.0269612.ref003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic Cancer: A Review","volume":"326","author":"W Park","year":"2021","journal-title":"Jama"},{"issue":"6","key":"pone.0269612.ref004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"pone.0269612.ref005","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1053\/j.gastro.2005.03.035","article-title":"Surgery for pancreatic cancer: recent controversies and current practice","volume":"128","author":"CJ Wray","year":"2005","journal-title":"Gastroenterology"},{"issue":"9791","key":"pone.0269612.ref006","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"A Vincent","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"3","key":"pone.0269612.ref007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0968-0004(01)02052-7","article-title":"The MUC family: an obituary","volume":"27","author":"J Dekker","year":"2002","journal-title":"Trends in biochemical sciences"},{"issue":"1\u20132","key":"pone.0269612.ref008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10409239209082559","article-title":"Mucin-type glycoproteins","volume":"27","author":"GJ Strous","year":"1992","journal-title":"Critical reviews in biochemistry and molecular biology"},{"issue":"3","key":"pone.0269612.ref009","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-5606","article-title":"Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis","volume":"9","author":"S Wang","year":"2021","journal-title":"Annals of Translational Medicine"},{"issue":"7","key":"pone.0269612.ref010","first-page":"10274","article-title":"Clinicopathological and prognostic significance of MUC4 expression in cancers: Evidence from meta-analysis","volume":"8","author":"X Huang","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"6","key":"pone.0269612.ref011","doi-asserted-by":"crossref","first-page":"e0157878","DOI":"10.1371\/journal.pone.0157878","article-title":"Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis","volume":"11","author":"B Li","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"pone.0269612.ref012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MCG.0000000000000863","article-title":"Mucin Expression in the Esophageal Malignant and Pre-malignant States: A Systematic Review and Meta-analysis","volume":"52","author":"Y Niv","year":"2018","journal-title":"Journal of clinical gastroenterology"},{"issue":"6","key":"pone.0269612.ref013","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MCG.0000000000001050","article-title":"Mucin Expression in Colorectal Cancer (CRC): Systematic Review and Meta-Analysis","volume":"53","author":"Y Niv","year":"2019","journal-title":"Journal of clinical gastroenterology"},{"key":"pone.0269612.ref014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"JF Tierney","year":"2007","journal-title":"Trials"},{"key":"pone.0269612.ref015","first-page":"d2090","article-title":"How to obtain the confidence interval from a P value","volume":"343","author":"DG Altman","year":"2011","journal-title":"BMJ (Clinical research ed)"},{"issue":"8","key":"pone.0269612.ref016","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/MPA.0000000000000619","article-title":"Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients with Metastatic Pancreatic Adenocarcinoma","volume":"45","author":"E Dotan","year":"2016","journal-title":"Pancreas"},{"key":"pone.0269612.ref017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2018.01.017","article-title":"MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer","volume":"418","author":"K Fan","year":"2018","journal-title":"Cancer Letters"},{"issue":"12","key":"pone.0269612.ref018","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00535-003-1224-6","article-title":"Increased expression of MUC1 in advanced pancreatic cancer","volume":"38","author":"Y Hinoda","year":"2003","journal-title":"Journal of gastroenterology"},{"issue":"1","key":"pone.0269612.ref019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1385\/IJGC:34:1:09","article-title":"Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis","volume":"34","author":"M Jinfeng","year":"2003","journal-title":"International journal of gastrointestinal cancer"},{"issue":"11","key":"pone.0269612.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113309","article-title":"Unsupervised hierarchical clustering of pancreatic adenocarcinoma dataset from TCGA defines a mucin expression profile that impacts overall survival","volume":"12","author":"N Jonckheere","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"pone.0269612.ref021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1158\/1541-7786.MCR-16-0296","article-title":"Oncogenic KRAS targets MUC16\/CA125 in pancreatic ductal adenocarcinoma","volume":"15","author":"C Liang","year":"2017","journal-title":"Molecular Cancer Research"},{"issue":"8","key":"pone.0269612.ref022","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jcp.2004.023572","article-title":"MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas","volume":"58","author":"M Saitou","year":"2005","journal-title":"Journal of clinical pathology"},{"key":"pone.0269612.ref023","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jss.2017.11.009","article-title":"RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence","volume":"226","author":"K Sato","year":"2018","journal-title":"Journal of Surgical Research"},{"issue":"4","key":"pone.0269612.ref024","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1349-7006.2012.02214.x","article-title":"Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma","volume":"103","author":"A Shimizu","year":"2012","journal-title":"Cancer Sci"},{"issue":"4","key":"pone.0269612.ref025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/his.12994","article-title":"Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance","volume":"69","author":"M Sierzega","year":"2016","journal-title":"Histopathology"},{"issue":"10","key":"pone.0269612.ref026","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.humpath.2012.01.005","article-title":"Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon","volume":"43","author":"MM Streppel","year":"2012","journal-title":"Hum Pathol"},{"key":"pone.0269612.ref027","first-page":"11","article-title":"Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study","author":"JK Striefler","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"7","key":"pone.0269612.ref028","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1158\/0008-5472.CAN-08-3879","article-title":"Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray","volume":"69","author":"M Takikita","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"pone.0269612.ref029","first-page":"107","article-title":"Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors","volume":"24","author":"H Yamasaki","year":"2004","journal-title":"International journal of oncology"},{"issue":"3","key":"pone.0269612.ref030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPA.0000000000000283","article-title":"A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4","volume":"44","author":"K Yang","year":"2015","journal-title":"Pancreas"},{"issue":"27","key":"pone.0269612.ref031","doi-asserted-by":"crossref","first-page":"42553","DOI":"10.18632\/oncotarget.9924","article-title":"Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas","volume":"7","author":"S Yokoyama","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0269612.ref032","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12967-014-0309-8","article-title":"Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4\/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling","volume":"12","author":"Y Zhu","year":"2014","journal-title":"Journal of translational medicine"},{"issue":"SUPPL. 1","key":"pone.0269612.ref033","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1007\/s12032-010-9683-0","article-title":"The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma","volume":"28","author":"Y Zhu","year":"2011","journal-title":"Medical Oncology"},{"issue":"40","key":"pone.0269612.ref034","doi-asserted-by":"crossref","first-page":"67152","DOI":"10.18632\/oncotarget.17934","article-title":"Genomic alterations in mucins across cancers","volume":"8","author":"RJ King","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"pone.0269612.ref035","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.18632\/oncotarget.6819","article-title":"Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden","volume":"7","author":"L Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"pone.0269612.ref036","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/ijc.29242","article-title":"A preoperative serum signature of CEA+\/CA125+\/CA19-9 \u2265 1000 U\/mL indicates poor outcome to pancreatectomy for pancreatic cancer","volume":"136","author":"L Liu","year":"2015","journal-title":"International journal of cancer"},{"key":"pone.0269612.ref037","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/bs.pmbts.2019.01.005","article-title":"Serum CA153 as biomarker for cancer and noncancer diseases","volume":"162","author":"X Li","year":"2019","journal-title":"Progress in molecular biology and translational science"},{"issue":"5","key":"pone.0269612.ref038","first-page":"1085","article-title":"CA19-9 epitope a possible marker for MUC-1\/Y protein","volume":"18","author":"J Akagi","year":"2001","journal-title":"Int J Oncol"},{"issue":"1","key":"pone.0269612.ref039","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000048689","article-title":"De novo expression of the Muc2 gene in pancreas carcinoma cells is triggered by promoter demethylation","volume":"23","author":"A Siedow","year":"2002","journal-title":"Tumor Biology"},{"issue":"2\u20133","key":"pone.0269612.ref040","first-page":"336","article-title":"Knocking down of the MUC4 membranebound mucin and its membrane partner ErbB2 in human pancreatic cancer cells alter their in vitro and in vivo tumor properties","volume":"10","author":"N Jonckheere","year":"2010","journal-title":"Pancreatology: official journal of the International Association of Pancreatology (IAP)"},{"issue":"7","key":"pone.0269612.ref041","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/0008-5472.CAN-07-6041","article-title":"MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells","volume":"68","author":"P Chaturvedi","year":"2008","journal-title":"Cancer research"},{"issue":"7","key":"pone.0269612.ref042","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjc.6605285","article-title":"Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin","volume":"101","author":"S Bafna","year":"2009","journal-title":"Br J Cancer"},{"key":"pone.0269612.ref043","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/srep01870","article-title":"Mesothelin binding to CA125\/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation","volume":"3","author":"SH Chen","year":"2013","journal-title":"Scientific reports"},{"issue":"22","key":"pone.0269612.ref044","doi-asserted-by":"crossref","first-page":"19118","DOI":"10.18632\/oncotarget.4078","article-title":"MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism","volume":"6","author":"SK Shukla","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"pone.0269612.ref045","first-page":"126","article-title":"MUC1: a novel metabolic master regulator","volume":"1845","author":"K Mehla","year":"2014","journal-title":"Biochimica et biophysica acta"},{"issue":"40","key":"pone.0269612.ref046","doi-asserted-by":"crossref","first-page":"26985","DOI":"10.1074\/jbc.M805036200","article-title":"Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression","volume":"283","author":"PK Singh","year":"2008","journal-title":"The Journal of biological chemistry"},{"issue":"34","key":"pone.0269612.ref047","doi-asserted-by":"crossref","first-page":"13787","DOI":"10.1073\/pnas.1203339109","article-title":"MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer","volume":"109","author":"NV Chaika","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"pone.0269612.ref048","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","article-title":"MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer","volume":"32","author":"SK Shukla","year":"2017","journal-title":"Cancer cell"},{"issue":"19","key":"pone.0269612.ref049","first-page":"5881","article-title":"MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clinical cancer research: an official journal of the","volume":"23","author":"V Gunda","year":"2017","journal-title":"American Association for Cancer Research"},{"issue":"6","key":"pone.0269612.ref050","first-page":"1372","article-title":"Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy","volume":"7","author":"H Suh","year":"2017","journal-title":"American journal of cancer research"},{"issue":"1","key":"pone.0269612.ref051","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.gastro.2021.09.017","article-title":"Mucin 5AC Serves as the Nexus for \u03b2-Catenin\/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance","volume":"162","author":"K Ganguly","year":"2022","journal-title":"Gastroenterology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T08:39:30Z","timestamp":1700728770000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269612"}},"subtitle":[],"editor":[{"given":"Pankaj K","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0269612","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]}}}